The global Arachnoiditis market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of XX% throughout the estimate period from 2020 to 2027.
Arachnoiditis is a rare medical complication caused by damage or harm to the arachnoid layer of the spinal cord. The patient suffers from profound stinging, burning and neurological problems in this condition. Arachnoiditis is a result of unsuccessful surgery, the entrance of unwanted chemical in the spinal cord or viral and bacterial infection to the spinal cord. The growing geriatric population, an increasing number of surgeries, and technological advancement in the world is propelling the growth of the market. For instance, according to the United Nations, a population which is 60 or above 60-year-old is rapidly increasing and will reach 2.1 billion in 2050 from 936 million in 2017.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Arachnoiditis market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Arachnoiditis market growth.
The global Arachnoiditis market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Some of the key players in the global arachnoiditis market are Baxter, B. Braun Melsungen AG, Pfizer Inc., SR Pharma, Abbott, AstraZeneca, Bristol-Myers Squibb Company, DuPont, Sandoz International GmbH, Takeda Pharmaceutical Company Limited, and Novartis AG.
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
Global Arachnoiditis Market, by Type
Adhesive arachnoiditis
Cerebral arachnoiditis
Arachnoiditis ossificans
Hereditary arachnoiditis
Neoplastic arachnoiditis
Optochiasmatic arachnoiditis
Global Arachnoiditis Market, by Cause
Trauma/Surgery Induced
o Spinal Surgery
o Lumbar Puncture
o Spinal Stenosis
o Others
Chemically Induced
o Myelograms
o Epidural Steroid Injection
Infection-Induced
o Viral and Fungal Meningitis
o Tuberculosis
Global Arachnoiditis Market, by Diagnosis
CAT scan (Computerized Axial Tomography)
MRI (Magnetic Resonance Imaging)
Electromyogram (EMG)
Global Arachnoiditis Market, by Treatment
Physical Therapy
o Hydrotherapy
o Hydrotherapy
o Hot/Cold Therapy
Pain Medications
o Lidocaine Intravenous (IV) Infusion
o Ketamine IV Infusions
o Naltrexone
Nerve Stimulation
o Spinal Cord Stimulation
o Transcutaneous Electrical Nerve Stimulation (TENS)
Psychological Support
Global Arachnoiditis Market, by End User
Hospital and Clinics
Pharmacies
Diagnostic Centers
Others
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization